SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

FACTOR THERAPEUTICS LIMITED (FTT)

Suspended from ASX

SHARE PRICES

Former (or subsequent) names

Shareholder links

Our website ranking of FTT: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Link Market Services,Level 21, 10 Eagle Street Brisbane QLD 4000

Tel : +61 7 3320 2200 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000FTT2
Address: C/- Company Matters Pty Limited Level 21, 10 Eagle Street Brisbane QLD 4000
Tel:  07 3334 3900 Fax: 07 3334 3999

Date first listed: 19/03/2004
Company Secretary: Melanie Farris
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Provides wound healing, tissue repair and cell culture technology

The company releases the Results of its Meeting.

30/07/2020

The company releases its Chair Address to AGM and LONGMILE presentation.

30/07/2020

The company lodges its Appendix 4D and Report for half-year to 30 June 2020.

29/07/2020

The company will remain suspended following the announcement that it has entered into a term sheet relating to the negotiation and potential implementation of a transaction to acquire certain technologies from Brain Biosciences. FTT's securities will remain suspended until ASX is satisfied that all relevant information required under Guidance Note 12: Change to Activities has been announced. If the Acquisition proceeds, ASX is likely to exercise its discretions under Listing Rule 11.1.2 to require the Acquisition to be conditional on approval by FTT's ordinary security holders and under Listing Rule 11.1.3 to require FTT to recomply with Chapters 1 and 2 of the Listing Rules.

24/07/2020

The company has entered into a term sheet with Rockville-based Brain Biosciences, Inc. doing business as LONGMILE Veterinary PET Imaging, a commercial-stage veterinary medical technology company, relating to the negotiation and potential implementation of a transaction to acquire products and technologies for companion animal and equine veterinary imaging from LONGMILE.

24/07/2020

The company lodges its Appendix 4C and Activities Report - June 2020 Quarter.

23/07/2020

The securities of Factor Therapeutics Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of FTT, pending the release of an announcement regarding details of a proposed acquisition.

17/07/2020

name changed from Tissue Therapies Limited

05/05/2016

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    17/06/2014Iain Ross66,000$0.290$19,140
    04/03/2014Mel Bridges28,000$0.350$9,800
    03/03/2014Mel Bridges99,800$0.304$30,379
    02/12/2011Mel Bridges97,988$0.415$40,665
    30/11/2011Mel Bridges53,661$0.415$22,269

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    David BrookesChairman10/04/2019
    Nigel JohnsonCOO07/04/2015
    Christian BehrenbruchNon Exec Director12/10/2015
    John MichailidisNon Exec Director14/02/2017

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Cherrell HirstChairman30/06/200930/07/2020
    Timothy HughesNon Exec Director03/11/201415/05/2019
    Rosalind WilsonCEO19/06/201725/01/2019
    Robert P. RyanNon Exec Director13/09/201612/12/2018
    Mel BridgesNon Exec Director12/03/200925/11/2015
    Iain RossNon Exec Director25/05/201217/09/2015
    Drummond McKenzieCFO05/09/201112/08/2015
    Roger ClarkeChairman06/11/200331/05/2015
    Steven MercerDirector, CEO10/05/200607/04/2015
    Greg BayntonDirector31/12/200812/06/2012

    Date of first appointment, title may have changed.